Navigation Links
First Paralyzed Formula Race Car Driver's "Road to Indy" Sponsored By Coloplast
Date:5/15/2012

MINNEAPOLIS, May 15, 2012 /PRNewswire/ -- Coloplast North America, a provider of products and services for people with intimate medical needs, has announced a corporate sponsorship of Michael Johnson, formula racing's first paralyzed driver.

Johnson, 19, is competing this year in The Cooper Tires USF2000 Championship Powered by Mazda, the first step on the Road to Indy, an open-wheeled development program for drivers seeking a professional racing career. Johnson's goal is to be the first paralyzed driver to compete in the Indy500.

With modifications to his car and the use of medical devices, Johnson is able to compete at the professional level. One of those devices is Coloplast's SpeediCath® coated catheter providing hygienic, convenient catheterization.

"Coloplast's mission is to improve patient quality of life. Michael Johnson embodies that mission. He is redefining the sport and erasing boundaries, proving that with the right mix of innovation and passion, any obstacle can be overcome," said Tom Remmel, SpeediCath Product Manager. "We are proud to be part of this racing team and will be cheering for Michael every step of the way, especially when he crosses the finish line at Indy500 for the first time."

Coloplast's sponsorship provides financial support for Michael Johnson racing. Coloplast and SpeediCath logos will be displayed on Johnson's car and gear throughout the season.

"I sincerely appreciate Coloplast's support in pursuing my dream," Johnson said. "Their sponsorship fuels my team's aim to advance to the IndyCar series, and SpeediCath gives me the convenience and freedom to focus on my training."

A Lifelong Desire For Competition

In 2005, Johnson was a 14-time motorcycle-racing champion. He became paralyzed from mid-chest down after spinal cord injuries suffered in a dirt-track competition.

Despite having no feeling in his legs, Johnson never gave up his desire to race competiti
'/>"/>

SOURCE Coloplast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
2. PLC Systems Reports First Quarter 2012 Results
3. PGI Reports First Quarter 2012 Results
4. Medical Marijuana, Inc. Announces First Quarter 2012 Results
5. BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication
6. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
7. GeoVax Labs Reports 2012 First Quarter Financial Results
8. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
9. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. EntreMed Reports First Quarter 2012 Financial Results
11. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... August 3, 2015 BiondVax Pharmaceuticals Ltd. ... analysis of results from a study which demonstrates that BiondVax,s ... trial which took place in 2012, provided participants with increased ... time of the study- in particular the current newly emerged ... the United States in 2015. ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Sorrento ... that it has entered into an exclusive licensing agreement ... or biobetter antibodies from Mabtech Limited, a holding company ... China . Under the ... these 4 monoclonal antibodies (mAbs) for the North American, ...
(Date:7/31/2015)... July 31, 2015  Physicians and payers alone ... biopharmaceutical market. Patients are better informed and getting ... switching therapies. This shift in power is reshaping ... toward patient-focused marketing. As part of ... learned it,s important to educate, communicate and engage ...
Breaking Medicine Technology:Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2
... N.J., July 11, 2011 MonoSol Rx, a ... PharmFilm® technology platform, in collaboration with APR Applied ... that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble ... partners.  The Company made the strategic decision to ...
... YORK, July 11, 2011 Reportlinker.com announces ... available in its catalogue: ... approval brings lessons and hope to market ... To order this report: ...
Cached Medicine Technology:MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners 2MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners 3
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health ... on its website. , “Our ‘Ask a Nutritionist’ feature on our website is a ... healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health Food ...
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data ... IT to create efficiencies in healthcare information exchange, announced the release of its findings ... and Human Services (HHS) Secretary, WEDI shared survey results and recommendations ...
(Date:8/3/2015)... ... ... They know every second counts. And when it comes to stroke, the ... best care in the nation. For the past two months, the stroke team led ... time in the country. During the months of June and July, it took the ...
(Date:8/3/2015)... ... 03, 2015 , ... BESLER Consulting today announced the firm ... The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, and creative ... of their Readmissions Analytics product was selected as one of four finalists in ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s largest ... pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and other ... more than 8.6 million adverse drug events are reported in the U.S. ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3
... threeat to the globe as 95% of the AIDS ... General Assembly Special Session on HIV/AIDS, physicians demanded to ... would cater the AIDS victims in developing countries. ... (commonly known as Medicines Sans Frontieres, or MSF), MSF ...
... herbal product ginseng root has a number of psychological ... boosting mood performance. But researchers have found no psychological ... PhD, associate professor and co-director of the sport and ... Corvallis, Oregon and his colleague, Hermann Engles, PhD, conducted ...
... inherited disease of the nervous system due to the ... such as involuntary movements and balance problems and later ... well. ,All these days, until now, it was ... form of the protein 'huntingtin' which is responsible for ...
... bacteria known as E. coli 0157:H7 causes some of ... adults. Infections with this organism are often caused by ... to treat children with E. coli bacterial infection increases ... ,"Our data suggests that antibiotics are not only ...
... go in for strategic alliances among themselves to ... and precluding cut-throat competition which would be detrimental ... the Commerce Secretary, Mr. Prabir Sengupta, at the ... Pharmaceuticals and Cosmetics Export Promotion Council here on ...
... its true , this salient disclosure revealed its truth when ... Dr. Fernando D. Martinez ,According to Dr.Fernando D.Martinez and collegues ... between 6 and 11 years of age have a sevenfold ... any such associated risk of asthma even if they are ...
Cached Medicine News:Health News:Pharma cos must forge Strategic alliances 2
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
... LMW Automated Microplate ... choice for any laboratory. ... sensor allows a precise ... residual volume, digitally controlled ...
... ELx50 is a fast and versatile automated strip ... manifold. It is a self contained and programmable ... fluidic delivery from the gentle dripping of a ... pressure delivery systems. ELx50/12V processes 1 x 12 ...
... The Microplate washer MP-1200 is ... microplate washing system. Its internal micropumps ... and to discharge from all types ... microplate to be washed in rows ...
Medicine Products: